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Biotin synthase is responsible for the synthesis of bi-
otin from dethiobiotin and sulfur. Although the name
of the protein implies that it functions as an enzyme,
it has been consistently reported that biotin synthase
produces <1 molecule of biotin per molecule of pro-
tein in vitro. Moreover, the source of the biotin sulfur
atom has been reported to be the [2Fe-2S] center of
the protein. Biotin synthase has therefore been desig-
nated as a substrate or reactant rather than an en-
zyme. We report in vivo experiments demonstrating
that biotin synthase is catalytic but that catalysis puts
the protein at risk of proteolytic destruction.
Introduction
Escherichia coli biotin synthase (BioB), an S-adenosyl-
methionine-dependent radical enzyme, is required for
the last step of biotin synthesis, sulfur insertion into
dethiobiotin (DTB) (Figure 1). The composition of BioB
and the mechanism of its reaction are the subjects of a
large and often conflicting literature. A point of agree-
ment in the literature is that the BioB reaction is not
catalytic in vitro [1]. Despite extensive efforts over the
10 years since the in vitro activity was first demon-
strated [2], synthesis of <1 molecule of biotin per BioB
monomer has been consistently reported by many in-
vestigators [3–8]. Bio2, the BioB homolog of Arabidop-
sis thaliana, was reported to be very weakly catalytic in
a crude in vitro system [9], but a later report from the
same group using a purified system reported turnovers
of <1 [10] consistent with the BioB values. In the case
of BioB numerous and diverse justifications have been
put forth for the observed lack of catalysis, including
absence of an essential cofactor [11], intrinsically in-
active enzyme preparations [5], and inhibition by reac-
tion products [12], but no general agreement has
emerged. The currently favored and most provocative
explanation for the lack of catalysis is that the [2Fe-2S]
cluster of the protein provides the biotin sulfur atom
[6, 7, 13–16]. In this view BioB would be a reactant or
substrate rather than an enzyme and in the absence
of repair of the [2Fe-2S] center the protein would be
sacrificed. A serious limitation in evaluating this and
other proposals is that it has not been proven that BioB
is (or is not) catalytic in vivo; i.e., is BioB catalysis in
vitro an obtainable goal? It is not a given that BioB is
an enzyme because most organisms require only minis-
cule amounts of biotin (perhaps as little as a few hun-
dred molecules per cell). Hence, sacrifice of a BioB*Correspondence: j-cronan@life.uiuc.edumolecule for each biotin molecule synthesized is not
implausible. We report that E. coli BioB is intrinsically
catalytic in vivo. Twenty to sixty biotin molecules were
synthesized per molecule of BioB protein. However, the
view that BioB is sacrificed in its reaction remains ger-
mane since a significant fraction of the protein was de-
graded upon addition of DTB to the bacterial cultures.
We discuss our results in light of the recently reported
crystal structure of BioB [16].
Results and Discussion
Experimental Approach
Our experimental approach to measuring the catalytic
power of BioB in vivo is illustrated in Figure 2. A key
feature was that we measured biotin synthesis by a
new method, the covalent attachment of biotin to a
specific protein domain catalyzed by the E. coli BirA
biotin protein ligase (Figure 1B). This method was de-
veloped because the same detection method (antibody
and/or radioactive labeling) could be used to detect
and quantify both BioB and the modified (biotinylated)
biotin-accepting domain. This enabled us to directly
measure the ratio of biotin molecules formed per mole-
cule of BioB and thereby test catalysis in a straightfor-
ward manner. Moreover, in E. coli the synthesis and
covalent attachment of biotin are very tightly coupled
[17–19] and thus our assay was physiologically more
appropriate than the usual determination of free biotin.
Our biotin assay depended on the fact that DTB is a
much poorer (ca. 50,000-fold) substrate for the BirA
than biotin [20]. At the concentrations used BirA was
unable to attach DTB to acceptor proteins either in vivo
(Figure 3) or in vitro [20]. The acceptor protein was a
hexahistidine-tagged version of the 87 residue biotinoyl
domain of E. coli AccB [21], the biotinylated subunit of
acetyl-CoA carboxylase. This biotin acceptor domain
and BirA ligase (which biotinylates a specific lysine res-
idue of the domain [22–24]) were expressed from a T7
promoter plasmid (the powerful T7 promoter was used
to ensure that the biotin acceptor and ligase were in
excess over BioB). The host strain carried a deletion of
the entire bio operon including bioB such that the sole
source of BioB activity was a hexahistidine-tagged pro-
tein. The tagged BioB proteins were expressed from
genes that encoded fully active variants of BioB having
a hexahistidine tag on either the N terminus or the C
terminus. In these constructs BioB was expressed from
either an arabinose-inducible araBAD promoter on a
compatible multicopy plasmid or from the native bioB
promoter in its normal chromosomal location. It should
be noted that both termini of BioB protrude from the
structure and are highly mobile in the crystal structure
[16]. Similarly, the NMR [25] and crystal structures of
!AccB [26–28] show the N terminus of the protein to
be highly mobile. Therefore, the hexahistidine-tagged
versions of these proteins are expected to readily bind
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462Figure 1. The Biotin Synthase and Biotin Protein Ligase Reactions
The serrated line extending from the biotin acceptor domain repre-
sents the side chain of the lysine that is modified. The biotin syn-
thase (A) and biotin protein ligase (B) of E. coli are called BioB and
BirA, respectively, based on the names of the encoding genes.tag-specific affinity columns and antibodies (as we
have observed).
Addition of DTB Results in Degradation of BioB
E. coli strains carrying the appropriate plasmid(s) were
grown in the presence of near growth-limiting concen-
trations of biotin and then washed free of biotin (Figure
2A). The cells were then returned to growth medium
lacking biotin. The synthesis of BioB, the acceptor pro-
tein and BirA were induced (despite the lack of biotin
growth proceeds for at least four generations due the
preexisting supplies of biotinylated AccB and mem-
brane lipids). After induction had progressed, tetracy-
Fcline was added to block further protein synthesis. The
(cultures were then split into three flasks. One of these
mcultures was left without supplementation whereas the
w
other two received either dethiobiotin or biotin. Follow- (
ing incubation for various periods of time, the cells (
were collected, lysed, and the hexahistidine-tagged
proteins were quantitatively adsorbed to a column of
immobilized nickel. Following elution of unbound pro- I
steins, the tagged proteins were then eluted with imidaz-
ole and analyzed using two different gel electrophoresis c
tsystems (Figure 2B). In the first system, standard SDS-
PAGE resolved BioB from the biotin acceptor domain. figure 2. Experimental Design
A) The large and small ovals represent an E. coli cell and its plas-
ids, respectively. In some experiments 35S-methionine labeling
as omitted and the assays were performed by Western blotting
see text).
B) A cartoon showing the expected PAGE separations is shown.n the second PAGE system, a nondenaturing gel re-
olved the modified (biotinylated) form of the biotin ac-
eptor domain from the unmodified (apo) form. The bio-
inylated protein migrates more rapidly than the apo
orm due to loss of the charge of the modified lysine
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463Figure 3. Instability of BioB upon Addition of DTB
(A), (B), and (C) are two different gels. In (A) and (B) two identical gels were run in parallel and the proteins were transferred to Immobilon P
membranes. The proteins of one membrane (upper gel of each panel) were visualized by Western blotting with an anti-pentahistidine antibody
whereas the proteins of the other membrane (lower gel of each panel) were visualized by Western blotting with a streptavidin conjugate. In
(C), the proteins of the gel were transferred to an Immobilon P membrane that was cut into halves that contained the proteins from the top
and bottom halves of the gel. The proteins of the top halves were visualized by Western blotting with an anti-pentahistidine antibody whereas
the bottom half was exposed to the streptavidin conjugate. Note that the strain of lanes 9–12 lacked BioB and that BioB expression in lanes
13–15 was from a hexahistidine-tagged chromosomal allele of bioB rather than from an expression plasmid. Biotin or DTB was added as
shown. The streptavidin-reactive band above !AccB (which is the 87 residue C-terminal fragment of AccB) is the full-length AccB. Western
blots of nondenaturing gels with the anti-pentahistidine antibody showed that addition of biotin resulted in quantitative conversion of !AccB
to its biotinylated form (data not shown). Thus, both BirA and !AccB are present in large excess in the DTB-supplemented cultures.residue upon modification [21, 24] (the modified and
unmodified species comigrate on SDS-PAGE gels). The
BioB protein plus the biotinylated and unbiotinylated
forms of the AccB biotin acceptor protein were de-
tected by Western blotting with an anti-pentahisti-
dine antibody. In addition, the modified form of !AccB
could also be readily detected by Western blotting
with streptavidin, a protein that binds biotin and DTB
[29]. Note that streptavidin blotting also detected the
full-length version of AccB, an essential endogeneous
E. coli protein.
The striking result from the SDS-PAGE gels was that
the band corresponding to BioB was markedly de-
creased in cultures that contained both DTB and an
excess of biotin acceptor protein (Figure 3, upper pan-
els). The decreased intensity of the BioB band in the
DTB supplemented cultures correlated with modifica-
tion of the biotin acceptor domain (Figure 3, lower pan-
els). Modification was due to BioB-dependent conver-
sion of DTB to biotin because cells that lacked BioB
synthesized no modified acceptor domain when sup-
plemented with DTB (Figure 3, lower panels). Therefore,
appearance of the modified form of the biotin acceptor
domain in DTB-supplemented cultures denoted BioB
activity. In five such experiments the intensity of the
BioB band decreased by 50%–90% upon addition of
DTB. The loss of the BioB band upon DTB addition re-
quired high levels of the acceptor protein. When only
the endogenous biotin acceptor protein (the full-length
AccB) was present, the BioB band retained much of its
intensity (Figure 3). These results suggested that accu-
mulation of free biotin due to limiting acceptor proteinmight inhibit the action of BioB on DTB. Consistent with
this premise, addition of biotin together with DTB gen-
erally resulted in higher levels of the BioB band than
those seen with addition of only DTB (Figure 3). Note
that upon addition of biotin in place of DTB a large in-
crease in modified biotin acceptor domain was seen
indicating that the ligase and acceptor domain were in
great excess over that needed to utilize the small
amounts of biotin made by BioB (Figure 3).
A potential difficulty in interpretation of these results
was the report that overproduction of BioB in aerobi-
cally grown cells results in protein preparations that
lack the [4Fe-4S] center required for biotin synthesis
[5]. This raised the possibility that the BioB protein re-
maining in the DTB-supplemented cultures might have
survived because it was inactive. To test this possibility
we examined the fate of BioB synthesized at a physio-
logical level (about 20-fold lower than the levels made
by the plasmid construct) by using homologous recom-
bination to replace the chromosomal bioB gene with a
modified version encoding a C-terminally hexahisti-
dine-tagged BioB [30]. Thus, expression of this hexa-
histidine-tagged BioB protein was under control of the
native bioB promoter and was induced by biotin limita-
tion (part of bioF was removed in inserting the tag re-
sulting in biotin auxotrophy). The E. coli strain was then
grown as in Figure 2 except that expression of the
BioB-hexahistidine protein was induced by biotin de-
privation and thus addition of DTB or biotin was corre-
spondingly delayed. The tagged BioB was then reco-
vered in concentrated form by affinity chromatography



































rFigure 4. Assay of BioB Catalysis
aIn each panel, the left-hand gel is an SDS-PAGE separation of
nhexahistidine-tagged versions of BioB (ca. 41 kDa) and !AccB (ca.
8.2 kDa, although it migrates as a larger protein in SDS-PAGE), r
whereas the right-hand band is a nondenaturing PAGE separation w
of the biotinylated (holo) and apo forms of !AccB due to the charge l
difference imparted by the modification. (A) and (B) are proteins
ofrom the same 35S-methionine labeled cultures in which BioB was
aoverproduced with detection by radioactivity or by Western blot-
Bting, respectively. (C) Expression of BioB at a physiologically ap-
propriate level with detection by Western blotting. A contaminant W
band that migrates between the two proteins of interest was some- a
times seen. The molecular ratios of biotin synthesized per BioB n
monomer were 58.4, 22.2, and 39.3 in the experiments of (A), (B),
(and (C), respectively. The band between the BioB and !AccB that
asometimes appears is believed to be a contaminating host protein.
oIt cannot be a BioB degradation product since it was observed in




thistidine antibody (Figure 3, upper panels). As pre-
viously seen when BioB was overproduced, DTB addi- e
4tion resulted in loss of the BioB band. As expected the
decrease in the BioB band was accompanied by in- t
tcreased attachment of biotin to AccB as assayed by
Western blotting with streptavidin (Figure 3, lower pan- s
lels). (Since in wild-type cells the levels of AccB biotin
acceptor protein and BirA biotin ligase are in excess k
iover the levels required to attach the synthesized biotino protein [17–19], the plasmid expressing !AccB and
irA was omitted from this strain.)
We believe that the loss of the BioB band indicates
egradation of the protein to small peptides. It was also
ossible that the His-tag was clipped from the protein.
owever, hexahistidine tags attached to either end of
ioB were examined and thus clipping seems unlikely.
oreover, in some experiments the overproduced BioB
ands were serendipitously resolved from the other
rotein bands on SDS gels and hence visible on Coo-
assie Blue-stained gels. Although BioB bands were
resent in the biotin-treated and untreated cultures, no
and was visible in the samples from DTB-treated cul-
ures. It is possible that BioB degradation is the result
f induction of a stress response by protein overex-
ression [31]. However, this seems unlikely since deg-
adation is specifically triggered by DTB addition (Fig-
res 3 and 4).
toichiometry of the Biotin Synthase
eaction In Vivo
lthough these assays demonstrated the dependence
f BioB levels upon dethiobiotin addition and quantita-
ive densitometry of the Western blots of several exper-
ments indicated that 20–60 molecules of biotin had
een formed per molecule of BioB, we also measured
his ratio by a more direct assay. Following induction of
ioB, BirA, and !AccB, the cellular proteins were la-
eled by incorporation of 35S-methionine for 3 hr (Fig-
re 4A). Tetracycline was then added to block further
ncorporation and the cultures were incubated over-
ight. The radioactive hexahistidine-tagged proteins
ere quantitatively recovered from the nickel chelate
olumn and subjected to electrophoresis in the two gel
ystems. The intensities of the radioactive bands of the
esulting gels were then quantitated by phosphorim-
ging. From the numbers of BioB and !AccB methio-
ine residues/monomeric protein plus the levels of
adioactivity of the BioB and modified !AccB bands, it
as straightforward to calculate the number of biotiny-
ated acceptor domain molecules formed per molecule
f BioB monomer. These experiments gave values of
bout 50 molecules of biotin formed per molecule of
ioB monomer. The values given by the radioactive and
estern blot assays were shown to be in reasonable
greement (<3-fold variation) by performing the immu-
ological analyses on 35S-methionine labeled samples
Figure 4B). We believe that the values given by radio-
ctive labeling experiments are more accurate because
f the direct nature of the assay and the fact that phos-
horimaging analysis is linear over the large dynamic
ange of the experiment (whereas quantitation of West-
rn blots requires a series of calibrations). The levels of
ioB produced by the chromosomal bioB gene were
oo low for effective 35S-methionine labeling so these
xperiments were assayed by Western blotting (Figure
C) and gave BioB turnover values similar to those ob-
ained when BioB was overproduced. Thus, it seems
hat overproduced BioB is fully active, although it
hould be noted that our levels of overproduction were
ower than those used by others [3–5, 7, 8, 32, 33]. The
inetics of BioB action in vivo have not been explored
n depth because of the instability of the protein. This
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465Table 1. Oligonucleotide Primers Used






BioB-g-HIS-RE GCGATCATCCGCCACCAGCCAGCGTCCGGCTCCTTGCGCCACCGGATAACGCATATGAATATCCTCCTTAGinstability results in kinetic uncertainties such as the
timing of biotin synthesis relative to that of protein deg-
radation. Indeed, even in the defined in vitro systems
there are disagreements concerning whether or not the
time of [2Fe-2S] cluster disappearance correlates with
that of biotin formation [6, 34]. However, although we
were unable to examine early time points when BioB
was not overexpressed due to the insensitivity of our
assay (an appreciable fraction of the acceptor domain
must become biotinylated), we did assay some earlier
time points when BioB was overexpressed. For exam-
ple, following a 3 hr induction of BioB synthesis, tetra-
cycline was then added and samples were taken fol-
lowing 4 hr and 16 hr of further incubation. When
expressed per the initial number of monomeric BioB
molecules these samples showed formation of 19 and
63 molecules of biotin, respectively.
Conclusions
Our data indicate that BioB is catalytic and is a true
enzyme rather than a substrate or reactant. However,
BioB is an enzyme of very modest catalytic power. In
our work we observed synthesis of only tens of biotin
molecules per BioB molecule. On the other hand, there
is no need for E. coli biotin synthase to be an efficient
catalyst since E. coli (like most other organisms) re-
quires only minuscule quantities of biotin for growth.
E. coli can grow with only 100–200 molecules of biotin
per cell [35, 36]. We envision the observed degradation
of BioB to result from collapse of the enzyme [2Fe-2S]
center due to donation of a sulfur atom to DTB [6, 7,
13–16]. The [2Fe-2S] center of BioB is located deep
within the barrel of this α/β8 (TIM) protein [16] and thus
it seems probable that a substantial unfolding of the
protein would be required to allow rebuilding of the
[2Fe-2S] cluster. Such unfolding would allow restora-
tion of the [2Fe-2S] center, but at the cost of exposure
of the protein to proteolytic attack while unfolded.
Therefore, in this scenario catalysis by a molecule of
BioB would require the protein to run a gauntlet of pro-
teolysis until restoration of normal folding (with con-
comitant resistance to proteolysis) by rebuilding of the
[2Fe-2S] center expended in biotin synthesis. Thus, we
view the turnover numbers we measured as the prod-
ucts of a stochastic process. If the [2Fe-2S] cluster of
a BioB molecule is rebuilt before proteolysis occurs,
that protein will perform another turnover. If not, the
protein molecule perishes and must be resynthesized
de novo. Hence, some BioB molecules would catalyze
only one or a few turnovers in their lifetimes whereas
others may complete >100 turnovers. The question of
how the BioB sulfur centers are inserted and restoredremains an open question. Although BioB has recently
been reported to accept a [4Fe-4S] center from two
E. coli Fe-S center scaffold proteins, SufA and IscA, no
[2Fe-2S] center was formed [37].
Significance
Although biotin (vitamin H) is required for essential
carboxylation and decarboxylation reactions through-
out biology, the complete biotin biosynthetic pathway
is not understood in any organism. The most chemi-
cally difficult reaction in the pathway is the last step,
insertion of a sulfur atom into dethiobiotin to form
biotin. Although biotin synthase, the protein respon-
sible for this reaction, functions in vitro, <1 molecule
of biotin is formed per molecule of protein. Moreover,
a protein bound [2Fe-2S] center has been reported to
be the sulfur donor. For these reasons biotin syn-
thase has been designated as a reactant or substrate
rather than an enzyme. We have asked if biotin syn-
thase is catalytic in vivo and have found that 20–60
molecules of biotin are formed per molecule of pro-
tein. However, upon addition of dethiobiotin a signifi-
cant fraction of the biotin synthase is destroyed by
proteolysis. We suggest that this degradation is a
consequence of unfolding of the protein to allow re-
placement of the [2Fe-2S] center consumed in biotin
synthesis. Most organisms require only miniscule
amounts of biotin (perhaps as little as a few hundred
molecules per cell) and thus sacrifice of a biosyn-
thetic protein may not be unreasonable. Since biotin
synthase is catalytic in vivo, it should be possible to
demonstrate catalysis by the enzyme in vitro. If, how-
ever, the [2Fe-2S] center of the enzyme donates the
biotin sulfur atom, then a better understanding of the
pathway for repair of the [2Fe-2S] center must be ob-
tained before BioB catalysis in vitro will be possible.
Similar considerations may apply to lipoic acid syn-
thase, the protein that inserts the sulfur atoms of this
essential aerobic metabolism cofactor.
Experimental Procedures
Plasmid Constructions
Plasmid pCY570 was digested with NcoI and treated with T4 DNA
polymerase plus the four deoxynucleotide triphosphates to blunt
the ends, followed by cutting with SalI to obtain a 2 Kb fragment
containing the bioB gene plus a fragment of the downstream bioF
gene. This fragment was ligated to pET28b (Novagen) that had
been digested with NheI, treated with DNA polymerase as above,
and then digested with SalI, resulting in pER29. Plasmid pER29
was digested with NcoI plus HindIII and ligated to plasmid pBAD24
cut with same enzymes to give pER30. Plasmid pER30 was cut
with NsiI plus HindIII and the bioBF# fragment ligated to pBAD30
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466cut with same enzymes to give pER31 that encoded a BioB protein 1
acarrying an N-terminal hexahistidine tag under control of the ara-
BAD promoter. Plasmid CY142 was cut with NcoI treated with DNA O
apolymerase as above and then digested with SalI to obtain a 280
bp fragment encoding the C-terminal end of AccB (the 87 residue b
6biotin domain). This fragment was ligated to pET28b that had been
cut with NheI, treated with DNA polymerase as above, and then a
pdigested with SalI affording pER32. The birA gene was amplified
from plasmid BirA WT HIS6 [38] with Pfu Turbo DNA polymerase N
lwith primers birA up and birA down (Table 1) and the product was
inserted into pCR2.1-TOPO (Invitrogen) to give pER33. Plasmid t
pER33 was cut with EcoRI and treated with T4 DNA polymerase as
above, followed by cutting with HindIII to obtain a 1 Kb fragment a
icontaining a birA gene that encoded a protein that lacked the hexa-
histidine tag. This fragment was ligated to pET28b that had been f
ocut with NheI, treated with DNA polymerase as above, and then
digested with HindIII to give pER34. Plasmid pER34 was cut with T
aXbaI and treated with T4 DNA polymerase as above, followed by
cutting with XhoI to obtain the birA gene fragment that was ligated a
ato pER32 (which had been cut with SalI, treated with DNA polymer-
ase as above, and digested with XhoI) to give pER35. Plasmid
NpER35 was used to express the N-terminal hexahistidine-tagged
biotin acceptor domain and BirA proteins from a T7 promoter. Plas- i
cmid pER35 was cut with NcoI plus XhoI and then ligated to pBAD24
cut with the same enzymes to give pER84 that expressed the a
(N-terminal hexahistidine-tagged biotin acceptor domain and BirA
proteins from the araBAD promoter. t
dStrain NRD25 was constructed by N. Delay of this laboratory by
replacing the entire bio operon (bioABFCD) with a chloramphenicol E
dresistance cassette in strain MC1061 [39]. Plasmid pKD3 and pri-
amers BioKO For and BioKO Rev (Table 1) were used in PCR amplifi-
ccations. The deletion/insertion was verified by colony PCR analysis
sand the growth requirement of the strain for biotin. The chloram-
3phenicol resistance cassette was removed from NRD25 by Flp-cat-
jalyzed site-specific recombination [39] to give strain ER46. Strain
vER47 was constructed by integration of the λDE3 prophage into
tstrain ER46 using the λDE3 lysogenization kit from Novagen. Plas-
tmids pER31 and pER35 were introduced into ER47 strain to allow
texpression of the N-terminally hexahistidine-tagged BioB, the
oN-terminally hexahistidine-tagged biotin acceptor domain, and
TBirA proteins in a Dbio strain such that there was no source of DTB
aor untagged BioB. Strain ER90 contains a chromosomal bioB gene
ithat encodes a protein carrying a C-terminal histidine tag inserted
ain place of the native bioB. This strain was constructed using a
modification [30] of the Datsenko and Warner method [39]. Plasmid
tpKD3 was amplified with Taq DNA polymerase using primers BioB-
tg-C-HIS-FA and BioB-g-HIS-RE (Table 1). BioB-g-C-HIS-FA con-
btained a 5# segment homologous to the 3# end of bioB (lacking the
jtermination codon) followed by sequences encoding a hexahisti-
hdine tag plus the pKD3 priming site, whereas BioB-g-HIS-RE con-
stained sequences homologous to a sequence close to the 5# end
aof bioF plus the pKD3 priming site. Strain ER90 was verified by
pcolony PCR, followed by sequencing of the PCR product plus the
abiotin requirement due to inactivation of bioF by deletion of the
asegment encoding the first 22 residues.
p
a
Protein Expression and Analyses n
Plasmid pER31 carrying a bioB gene that encoded a hexahistidine-
tagged protein and pER35 that encoded the 87 residue C-terminal
Aregion of AccB (!AccB) having an N-terminal hexahistidine tag plus
the birA gene were transformed into E. coli strain ER47. Cultures
Twere grown in medium A (medium M9 plus 1% Vitamin Assay Cas-
tamino Acids, 0.2% glucose, 50 g/ml kanamycin, 30 g/ml chlor-
amphenicol, and 4 nM biotin) overnight at 37°C. The cells of the
overnight cultures were collected by centrifugation and washed R
with biotin-free medium A. The cells were then suspended in biotin- R
free medium A containing antibiotics as above to an optical density A
of 0.6 at 600 nm and grown for 2 hr at 37°C. The three proteins P
(BioB, BCCP, and BirA) were expressed by resuspending the cells
in medium B (M9 plus 1% Vitamin Assay Casamino Acids, 0.2% R
glycerol, 1 mM IPTG, 0.25% arabinose, and antibiotics as above to
an OD at 600 of 1.0). In some cases the cultures also received 3
Ci/ml of L-[35S]methionine (Amersham) (final concentration of ca..7 mCi/mmol calculated from the amino acid composition of Cas-
mino Acids). These cultures were then split into three subcultures.
ne subculture received water, another received DTB to 5 M, and
third received biotin to 5 M. The subcultures were then incu-
ated for 3 hr at 37°C at which time tetracycline HCl was added to
0 g/ml to the three subcultures followed by incubation overnight
t 30°C. The cells were then harvested by centrifugation, resus-
ended in lysis buffer (50 mM sodium phosphate [pH 8.0], 300 mM
aCl, 0.1 mM DTT, and 2 mM phenylmethylsulfonyl fluoride), and
ysed by sonication. The crude extracts were analyzed by gel elec-
rophoresis (see below).
Strain ER90 was grown in medium A containing 30 g/ml chlor-
mphenicol and 4 nM biotin overnight at 37°C. BioB protein was
nduced by resuspending cells from the overnight cultures in biotin-
ree medium A with 30 g/ml chloramphenicol to an optical density
f 0.6 at 600 nm after washing the cells with biotin-free medium A.
he culture was grown for 6 hr at 37°C and then tetracycline was
dded as above and the culture was split into thirds as described
bove and incubated overnight at 37°C. The cells were harvested
nd processed as described above.
Plasmid pER84 (which encoded an 87 residue !AccB having an
-terminal hexahistidine tag plus the birA gene) was transformed
nto strain ER90. Cultures were grown in medium A with 30 g/ml
hloramphenicol, 100 g/ml ampicillin, and 4 nM biotin overnight
t 37°C. Expression of BioB was induced by resuspending the cells
after washing the cells with biotin-free medium) of overnight cul-
ures in biotin-free medium A with antibiotics as above to optical
ensity of 0.6 at 600 nm and growth of the culture for 5 hr at 37°C.
xpression of the biotin acceptor and BirA proteins was then in-
uced by resuspending the cells in medium B with antibiotics as
bove and growing for 2 hr at 37°C followed by addition of tetracy-
line to 60 g/ml. The culture was then split into thirds as de-
cribed above and the subcultures were incubated overnight at
7°C. The cells were then harvested, lysed by sonication, and sub-
ected to Ni-chelate agarose chromatography as described pre-
iously [40]. The hexahistidine-tagged proteins bound quantita-
ively to the columns as shown by the lack of tagged proteins in
he loading and wash fractions as assayed by Western blotting with
he Penta-His antibody (see below) and the failure of the proteins
f the flow-though fraction to bind to a second Ni-chelate column.
he column elution conditions gave quantitative elution of BioB
nd !AccB as shown the finding that increased concentrations of
midazole gave no further elution. The fractions containing the hex-
histidine-tagged proteins were separated by PAGE (Figure 2).
PAGE gels were 12% polyacylamide run as before [40, 41] except
hat the SDS was omitted from the buffers used with the nondena-
uring gels. The proteins were transferred to an Immobilon-P mem-
rane (Millipore). Western blotting with a streptavidin-enzyme con-
ugate was done exactly as described previously [41]. Detection of
exahistidine-tagged proteins was done by the ECL system (Amer-
ham) after treating the membranes with the Penta-His monoclonal
ntibody (Qiagen) as primary antibody followed by a horseradish
eroxidase-coupled sheep anti-mouse IgG (Amersham) as second-
ry antibody. For radioactively labeled proteins the gels were dried
nd clamped to a Fujifilm imaging plate. Following exposure the
late was read in an FLA-3000 scanner. This imaging system gives
linear response with radioactive dose over five orders of mag-
itude.
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